In chronic neurodegenerative diseases of the brain, such as Multiple sclerosis, Alzheimer's disease and HIV-dementia, CCL5 signaling is associated not only with its classical definition as a chemoattractant for monocytes [31-36], but also with the initiation of neuroprotective mechanisms in neurons [33]. This evidence concerns the gene CCL5 and dementia.